Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-25 @ 7:54 PM
Study NCT ID:
NCT03468335
Status:
COMPLETED
Last Update Posted:
2025-04-17
First Post:
2018-01-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy
Sponsor:
AIO-Studien-gGmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-19
First Submit QC Date:
None
Study First Post Date:
2018-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-15
Last Update Post Date:
2025-04-17
Last Update Post Date Type:
ACTUAL